semaglutide compounding pharmacy ohio Shrivers Pharmacy How Compounded GLP-1s Are Challenging

England ML, Hartnell JM, Hershman JM, Levin SR

Key Facts The Absolute Risk Expansion: The calculated increase in absolute risk is remarkably small, manifesting as approximately 3 to 4 additional cases of ischemic optic neuropathy per 10,000 patients treated with GLP-1 receptor agonists over a standard 18-month therapeutic window

Branded pens lock you into specific dose steps (2.5, 5, 7.5, 10, 12.5, 15 mg for Mounjaro)

These include: Nausea Vomiting Diarrhoea Constipation Abdominal discomfort or bloating Reduced appetite (which may be intentional but can become excessive) These effects are typically most pronounced during the dose-escalation phase and tend to diminish as the body adjusts to the medication

BMI cutoffs for defining overweight and obesity vary by races and ethnicities

& Prescott, L